By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Crown Bioscience, Inc. 

4008 Burton Drive

Santa Clara  California  95054  U.S.A.
Phone: 617-818-2285 Fax: 408-986-0019


SEARCH JOBS
Crown Bioscience, Inc. is a premium biology CRO, providing discovery and early development solutions for global biotech and pharmaceutical companies. It is headquartered in the Silicon Valley, with wholly owned research centers in Beijing, China and Indianapolis. Crown Bioscience is the leader in providing high-quality and cost-effective services in preclinical oncology. Our services include target protein expression, purification and crystallization, in vitro/in vivo pharmacology, non-GLP toxicology, PK/PD, and translational research with patient-derived cell lines and animal models.

For more information, please visit our web site at www.crownbio.com.


Key Statistics


Email: apandey@crownbio.com
Ownership: Private

Web Site: Crown Bioscience, Inc.
Employees:
Symbol: 
 



Industry
Pharmaceutical

Segment
Oncology





Company News
Crown Bioscience, Inc. Reveals Strategy For Combining Drug Therapy With Irradiation to Overcome Resistance To Oncology Therapeutics 6/19/2014 9:16:28 AM
Crown Bioscience, Inc. To Showcase Progression In Human Surrogate Trials At The 50th American Society of Clinical Oncology Annual Meeting 5/30/2014 9:46:51 AM
Crown Bioscience, Inc. Raises $26.6 Million In Series D Round 5/23/2014 8:55:04 AM
Crown Bioscience, Inc. Passes 1000 Model Mark In PDX Collection For Oncology Drug Discovery 4/24/2014 10:28:12 AM
Shanghai Institute of Materia Medica And Crown Bioscience, Inc. To Collaborate On Cancer Center In China 11/27/2013 8:32:22 AM
PRECOS Announces World Pharma Congress 2013 Co-Presentation With Crown Bioscience, Inc. Illustrating the Benefits of Clinically Relevant PDX Models for Oncology Drug Discovery 11/1/2013 11:08:30 AM
Crown Bioscience, Inc. Enhances Oncology Research Services With Targeted Beam Radiation Therapy Via Business Collaboration With Xstrahl Limited 10/16/2013 11:32:49 AM
PRECOS Highlights Latest Advances in PDX Modelling for Oncology Drug Discovery to Increase Effectiveness of Drugs for Cancer Patients 9/13/2013 11:08:46 AM
Crown Bioscience, Inc. Strengthens Oncology Expertise With Acquisition of PRECOS Ltd 7/30/2013 10:09:40 AM
Crown Bioscience, Inc. and Beijing Purunao Team Up to Develop Cancer Drugs 11/28/2012 12:38:24 PM
12
//-->